The development of shock-proof "contact therapy" units, both of the water and of the air-cooled type, has helped solve many of the radiologic problems associated with such lesions. These units incorporate a small mobile shock-proof tube of low voltage, short targetskin distance and minimal fil...
People with a diagnosed anxiety disorder may benefit from treatment includingcognitive behavioral therapy (CNT)ormedication.10Most people with social anxiety disorder can learn to overcome their fear response and maintain better eye contact. In this way, eye contact is just one aspect of social inter...
Eye has seen an increase in number of publications from all parts of the world. In this collection, we raise the awareness of global ophthalmology as a speciality. The publications highlight regional variations in prevalence and incidence of various eye conditions, barriers and facilitators of eye...
EYE ON THERAPY: Dealing with Drooling: Getting rid of excess saliva goes high‐techAn abstract is unavailable.doi:10.1097/01.NNN.0000394654.99365.f8AMY PATURELNeurology Now
role played by the Trichoderma NoxR in the establishment of a fine‐tuned communication between the plant and the fungus even before physical contact. In... JM Villalobos〦Scobedo,S Esparza㏑Eynoso,R Pelagio〧Lores,... - 《Plant Journal》 被引量: 0发表: 2020年 SU〧㏄: Implementation of...
The eye-contact hypothesis suggests a clinical study addressing prevention: recruit prospective parents who agree to curtail television/video/computer/wi-fi in their families; measure autism’s incidence in their children. 1. Introduction This paper attempts to show why an experimental hypothesis is pl...
Papain therapy of adhesive processes in the eye LS Lutsker,MM Lenkevich,FI Mogilevskaia,... - 《Vestnik Oftalmologii》 被引量: 0发表: 0年 Papain-induced invitro disc degeneration model for the study of injectable nucleus pulposus therapy Papain-induced in-vitro disc degeneration model for the...
Reduced use of eye contact is a prominent feature in individuals with autism spectrum disorder (ASD). It has been proposed that direct gaze does not capture the attention of individuals with ASD. Experimental evidence is, however, mainly restricted to relatively high-functioning school-aged children...
New York-Pfizer Inc. and Eyetech Pharmaceuticals Inc. will jointly develop and commercialize Eyetech's pegaptanib sodium (Macugen) as a potential treatment for age-related macular degeneration (AMD) and diabetic macular edema (DME).